Suchergebnisse - "Iwanami, Shoya"

PubPharm (7)

1

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir

enthalten in: PLoS pathogens | 2023

von Torii, S. | Kim, K. | Koseki, J. | +15

2

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors

enthalten in: Journal of theoretical biology | 2023

von Tatematsu, D. | Akao, M. | Park, H. | +3

3

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

enthalten in: Antiviral research | 2022

von Ohashi, H. | Hishiki, T. | Akazawa, D. | +20

4

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection

enthalten in: PLoS computational biology | 2022

von Kumata, R. | Iwanami, S. | Mar, K. | +8

5

Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection

enthalten in: Life science alliance | 2021

von Kim, K. | Iwanami, S. | Oda, T. | +5

6

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials : A modeling study

enthalten in: PLoS medicine | 2021

von Iwanami, S. | Ejima, K. | Kim, K. | +17

7

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2

enthalten in: PLoS biology | 2021

von Kim, K. | Ejima, K. | Iwanami, S. | +11

1
[1]